Cost of Major Adverse Cardiac Events (MACE) among Type 2 Diabetes Mellitus (T2DM) Patients with Obesity, Renal Impairment, or Varying Cardiovascular Risk

被引：0
|
作者：
Johnston, Stephen
Shah, Manan
Sheehan, Jack
Cappell, Katherine
Princic, Nicole
Smith, David M.
Kalsekar, Iftekhar
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2441-PO
引用
收藏
页码：A619 / A619
页数：1
相关论文
共 50 条
  • [11] Adiponectin and vascular stiffness in youth with obesity and type 2 diabetes mellitus (T2DM)
    Gungor, N
    Thompson, T
    Sutton-Tyrrell, K
    Janosky, J
    Arslanian, S
    DIABETES, 2004, 53 : A68 - A68
  • [12] Association of Dietary Intake of Phosphorus with Obesity in Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
    Hatta, Mariko
    Fujihara, Kazuya
    Matsubayashi, Yasuhiro
    Takeda, Yasunaga
    Nedachi, Rina
    Ishii, Dai
    Horikawa, Chika
    Kato, Mitsutoshi
    Maegawa, Hiroshi
    Sone, Hirohito
    DIABETES, 2019, 68
  • [13] Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea
    Cho, Minho
    Park, Jong Suk
    Nam, Jisun
    Kim, Chul Sik
    Nam, Jae Hyun
    Kim, Hai Jin
    Ahn, Chul Woo
    Cha, Bong Soo
    Lim, Sung Kil
    Kim, Kyung Rae
    Lee, Hyun Chul
    Huh, Kap Bum
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (05) : 781 - 788
  • [14] Social isolation, loneliness and subsequent risk of major adverse cardiovascular events among individuals with type 2 diabetes mellitus
    Liang, Yannis Yan
    Chen, Yilin
    Feng, Hongliang
    Xue, Huachen
    Nie, Yu
    Ai, Qi-Yong H.
    Ma, Jiacheng
    Yang, Lulu
    Zhang, Jihui
    Ai, Sizhi
    GENERAL PSYCHIATRY, 2023, 36 (06)
  • [15] SYSTEMATIC REVIEW OF COST EFFECTIVENESS OF DAPAGLIFLOZIN TREATING PATIENTS OF TYPE 2 DIABETES MELLITUS (T2DM)
    Hu, C.
    Zhang, C.
    Wang, B.
    Xu, L.
    VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [16] Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Nissen, SE
    Wolski, K
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (20): : 2581 - 2586
  • [17] Saxagliptin Improves Glycemic Control and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus (T2DM) and Renal Impairment Compared with Placebo
    Owens, David R.
    Swallow, Ros
    Jones, Peter
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    DIABETES, 2010, 59 : A149 - A150
  • [18] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [19] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [20] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
12345